The global Colposcopy Market size is expected to reach USD 761.2 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.8% from 2022 to 2030. Increase in the prevalence of cervical cancer, technological advancements, and the rising demand for early- diagnosis of gynecological disorders are expected to boost the market growth. According to the ICO Information Centre on HPV and Cancer, cervical cancer is the fourth most frequent cancer among women globally, with an estimated 604,127 new cases and 341,831 deaths in 2020.
An article published by the Human Papillomavirus
Information Center stated that cervical cancer is reported to be the second
most common cancer among women aged 15 to 44. Colposcopy helps in accurate
identification of cervical pre-cancer and early invasive cancer. Moreover,
colposcope directed biopsies of severe lesion visualized help in further
management of the disease. Growing awareness and rise in the number of
screening campaigns for cervical cancer conducted by governments of various
regions are expected to fuel the market growth during the forecast period.
In the U.S., National Breast and Cervical Cancer Early
Detection Program (NBCCEDP) offers breast and cervical cancer screening and
diagnostic services to low-income, uninsured, and underinsured women across the
country. Several obstacles arose as a result of the COVID-19 pandemic,
including logistical constraints, low demand, and reduced sales and marketing
activities. However, by mid-2022, the market is predicted to be steadily
improving. By encouraging end-users to embrace high-end technologies for early
diagnosis of the disease, aiming to lessen cervical cancer cases by 70%, and
thus preventing over 4.5 million deaths (Source: WHO). This is expected to
significantly boost the market in the coming years.
Related Press Release @ Colposcopy Market Report
Colposcopy Market Report
Highlights
- The optical colposcopy segment dominated the market and is further
expected to continue its dominance over the forecast period, as the
adoption of optical colposcope is high in developing regions
- The video colposcopy segment is expected to grow at the fastest
rate during the forecast period
- Based on application, the oral examination segment is expected to
grow the fastest rate during the forecast period and also held the largest
revenue share in 2021
- Based on portability, the handheld segment is estimated to register
the fastest growth rate during the forecast period, owing to its ease of
use and compact nature
- The hospital segment held the largest revenue share based on
end-use in 2021
- North America dominated the market and accounted for the largest
revenue share in 2021
- In Asia Pacific, the market is anticipated to witness the fastest
CAGR over the forecast period owing to the growing need for
technologically advanced and cost-effective healthcare solutions
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment